Literature DB >> 8638996

Comparison of elderly and younger patients with out-of-hospital chest pain. Clinical characteristics, acute myocardial infarction, therapy, and outcomes.

D D Tresch1, W J Brady, T P Aufderheide, S W Lawrence, K J Williams.   

Abstract

BACKGROUND: Acute myocardial infarction is associated with significantly higher mortality in elderly patients compared with younger patients.
OBJECTIVES: To determine clinical differences in elderly and younger patients with acute myocardial infarction. To assess differences in therapies and outcomes between the age groups.
METHODS: Over a 3.5-year period, 2482 consecutive adult emergency medical services patients with chest pain received prehospital electrocardiograms and were entered in the Milwaukee Prehospital Chest Pain Database in Milwaukee, Wis. Clinical characteristics that included cardiac history, description of chest pain, time of onset to presentation, and prevalence of acute myocardial infarction were obtained for all patients. Patients with acute infarction were further analyzed in reference to type of infarction (Q wave vs non-Q wave), therapeutic interventions, and mortality. Patients were stratified in 3 age groups: younger than 70 years (younger), 70 years or older (elderly), and 80 years or older (very elderly); differences were compared among the age groups.
RESULTS: Even though more than 50% had a history of documented coronary artery disease, elderly patients with ischemic chest pain delayed more than 6 hours in seeking medical assistance after onset of pain. In elderly patients whose chest pain represented an acute myocardial infarction, hospital mortality was double that of younger patients. Thrombolytic therapy reduced hospital mortality by approximately 50% in both younger and elderly patients, although thrombolytic therapies were used in only 17% of the elderly patients compared with 50% of the younger patients (P < .001). Revascularization procedures were also beneficial in elderly patients as well as in younger patients, although this procedure, as with thrombolytic therapy, was less frequently used in elderly patients (48% vs 32%, P < .001).
CONCLUSIONS: Effective methods for reducing time delays from onset of chest pain to accessing health care for elderly persons deserve investigation. Physicians should be aware of the benefits of thrombolytic and revascularization therapies in elderly patients with acute myocardial infarction.

Entities:  

Mesh:

Year:  1996        PMID: 8638996

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Clinical profile of acute myocardial infarction in elderly patients.

Authors:  Lovleen C Bhatia; Ruchi H Naik
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

2.  [Elderly patients with cardiovascular diseases].

Authors:  U Müller-Werdan; M Meisel; P Schirdewahn; K Werdan
Journal:  Internist (Berl)       Date:  2007-11       Impact factor: 0.743

3.  Ischemic preconditioning in the younger and aged heart.

Authors:  Pasquale Abete; Gianluca Testa; Francesco Cacciatore; David Della-Morte; Gianluigi Galizia; Assunta Langellotto; Franco Rengo
Journal:  Aging Dis       Date:  2011-02-06       Impact factor: 6.745

Review 4.  Utilisation of thrombolytic therapy in older patients with myocardial infarction.

Authors:  K L Woods; D Ketley
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

5.  High prevalence of lack of knowledge of symptoms of acute myocardial infarction in Pakistan and its contribution to delayed presentation to the hospital.

Authors:  Muhammad S Khan; Fahim H Jafary; Azhar M Faruqui; Syed I Rasool; Juanita Hatcher; Nish Chaturvedi; Tazeen H Jafar
Journal:  BMC Public Health       Date:  2007-10-09       Impact factor: 3.295

6.  Differences of patients' perceptions for elective diagnostic coronary angiography and percutaneous coronary intervention in stable coronary artery disease between elderly and younger patients.

Authors:  Harald Rittger; Barbara Frosch; Laura Vitali-Serdoz; Matthias Waliszewski
Journal:  Clin Interv Aging       Date:  2018-10-10       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.